Melbourne event April 3rd, page-42

Hopefully you have learnt to show some patience by now within the Bio World given your ranting re CYP and their BOD's, which closed at $1.36 Friday incidentally, when in your highly informed view they had no idea what they were doing !!

IMU are at very early stages with their proof of concept with all 3 products so patience is very much required by all, they do however have the advantage of being in "different times bring different attitudes" in my opinion, whereby many of the big Pharmas are more inclined to pay a premium early on and take a gamble that their newly seduced "orphan" lives up to the promise shown early on and therefore justifying the financial gamble taken at the early stage.